The lithiumaluminumhydride reduction of 7-methoxychromanone oxime (I) and 7-methoxy-3-methylchromamone oxime (II) gave only the rearrangement product (the 2,3,4,5-tetrahydro-1,5-benzoxazepine derivative). 7-Methoxy-2-methylchromanone oxime (III) and 7-methoxy-2-isopropylchromanone oxime (IV) gave a mixture of the rearrangement product (secondary amine) and the normal reduction product (primary amine)
BENZOXAZEPINE DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR MODULATORS
申请人:JANSSEN PHARMACEUTICA N.V.
公开号:EP1778656A1
公开(公告)日:2007-05-02
[EN] BENZOXAZEPINE DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR MODULATORS<br/>[FR] DERIVES DE BENZOXAZEPINE COMME MODULATEURS SELECTIFS DU RECEPTEUR D'OETROGENE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2006023242A1
公开(公告)日:2006-03-02
The present invention is directed to novel benzoxazepine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and diseases mediated by an estrogen receptor.